Rockeby signs HK distributor

By Melissa Trudinger
Monday, 12 January, 2004

Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.

The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.

It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.

The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.

Related News

Widespread resistance to common antibiotics is increasing: WHO

Increasing resistance to essential antibiotics poses a growing threat to global health, with one...

Dopamine helps our brains to let go of memories

In a discovery that could reshape how we think about memory, researchers at Flinders University...

Vaccine for elephant herpesvirus found to be safe

The vaccine could prevent deadly elephant endotheliotropic herpesvirus in calves — the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd